User profiles for William Evans

William Evans

- Verified email at berkeley.edu - Cited by 79658

William E Evans

- Verified email at stjude.org - Cited by 73833

William N. Evans

- Verified email at nd.edu - Cited by 19482

Human aging, muscle mass, and fiber type composition

WJ Evans, J Lexell - The Journals of Gerontology Series A …, 1995 - academic.oup.com
To assess the age-related loss of muscle mass and to determine the mechanisms behind this
aging atrophy, the muscle structure and fiber type composition have been estimated, using …

Cachexia: a new definition

WJ Evans, JE Morley, J Argilés, C Bales, V Baracos… - Clinical nutrition, 2008 - Elsevier
On December 13th and 14th a group of scientists and clinicians met in Washington, DC, for
the cachexia consensus conference. At the present time, there is no widely agreed upon …

High-intensity strength training in nonagenarians: effects on skeletal muscle

…, ND Ryan, CN Meredith, LA Lipsitz, WJ Evans - Jama, 1990 - jamanetwork.com
Muscle dysfunction and associated mobility impairment, common among the frail elderly,
increase the risk of falls, fractures, and functional dependency. We sought to characterize the …

[BOOK][B] Trease and Evans' pharmacognosy

WC Evans - 2009 - books.google.com
This encyclopedic reference work on pharmacognosy covers the study of those natural
substances, principally plants, that find a use in medicine. Its popularity and longevity stem from …

[PDF][PDF] Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling

EJ Yeoh, ME Ross, SA Shurtleff, WK Williams, D Patel… - Cancer cell, 2002 - cell.com
Abstract Treatment of pediatric acute lymphoblastic leukemia (ALL) is based on the concept
of tailoring the intensity of therapy to a patient's risk of relapse. To determine whether gene …

Pharmacogenomics: translating functional genomics into rational therapeutics

WE Evans, MV Relling - science, 1999 - science.org
Genetic polymorphisms in drug-metabolizing enzymes, transporters, receptors, and other
drug targets have been linked to interindividual differences in the efficacy and toxicity of many …

[HTML][HTML] Exercise training and nutritional supplementation for physical frailty in very elderly people

…, JJ Kehayias, LA Lipsitz, WJ Evans - … England Journal of …, 1994 - Mass Medical Soc
Background Although disuse of skeletal muscle and undernutrition are often cited as
potentially reversible causes of frailty in elderly people, the efficacy of interventions targeted …

Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on …

RA Fielding, B Vellas, WJ Evans, S Bhasin… - Journal of the American …, 2011 - Elsevier
Sarcopenia, the age-associated loss of skeletal muscle mass and function, has considerable
societal consequences for the development of frailty, disability, and health care planning. A …

Pharmacogenomics—drug disposition, drug targets, and side effects

WE Evans, HL McLeod - New England journal of medicine, 2003 - Mass Medical Soc
It is well recognized that different patients respond in different ways to the same medication.
These differences are often greater among members of a population than they are within the …

Treatment of acute lymphoblastic leukemia

CH Pui, WE Evans - New England Journal of Medicine, 2006 - Mass Medical Soc
Although the overall cure rate of acute lymphoblastic leukemia (ALL) in children is about 80
percent, affected adults fare less well. This review considers recent advances in the …